RNAシーケンシング市場：第3版

シーケンス市場は、近い将来ヘルスケアに大きな変化をもたらすと期待される強力なツールを提供し続けています。過去10年間で、製品の導入、新しい用途、そしてこれらの新しい分野への参入を急ぐエンドユーザー研究所の面で、爆発的な成長が起こりました。近年、RNAシーケンシングがそれに取って代わり、それを凌駕するように台頭してきたため、RNA発現解析のためのマイクロアレイの使用は大きく減少しました。ゴールドスタンダードであった定量的逆転写PCR（q-RT-PCR）と同様に、マイクロアレイの大きな弱点の一つである予め定義されたプローブが必要であり、RNA-seqは多くの利点を提供しています。

当レポートでは、世界のRNAシーケンシング市場について調査し、市場の概要とともに、動向、課題、戦略、企業、製品について論じ、市場シェアと収益成長の推計を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場動向

• イントロダクション
• 動向
• 臨床診断、臨床調査への応用
• 癌- 白血病/血液疾患、固形腫瘍
• 感染症
• 希少遺伝性疾患/遺伝性疾患
• COVID-19
• Illuminaの多様な製品
• 他社のNGS製品・技術
• CDCのSPHERESコンソーシアム
• 新製品の継続的な導入
• 単一細胞RNAシーケンス
• 厳選した製品・技術
• ソフトウェア/バイオインフォマティクス
• 多くの分野でのパートナーシップ、買収、取引

第3章 市場分析

• 市場分析
• 市場シェア

第4章 企業プロファイル

• 企業プロファイル
  • 10X Genomics
  • Agilent Technologies
  • Illumina
  • New England Biolabs
  • Oxford Nanopore Technologies
  • Pacific Biosciences (PacBio)
  • Standard BioTools
  • Takara Bio Inc.
  • Tecan
  • Thermo Fisher Scientific

The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future. In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. In recent years, the use of microarrays for RNA expression analysis has dropped greatly as RNA sequencing has risen to replace and outshine it. Similar to quantitative reverse transcription-PCR (q-RT-PCR) which has been the gold standard, there is a need for pre-defined probes which creates one of the major weaknesses of microarrays, and RNA-seq provides a number of advantages including:

• improved sensitivity and dynamic range
• ability to study species without reference
• measurement of focal changes (such as single nucleotide variants, insertions and deletions)
• detection of different transcript isoforms, splice variants and chimeric gene fusions (including previously unidentified genes and/or transcripts)

This report, “The Market for RNA Sequencing, 3^rd Edition”, focuses on the market for RNA sequencing products - the hardware, service of the hardware, software, and consumables including for the sequencing step itself. It discusses trends, challenges, strategies, companies, and products, and provides estimates of market share and revenue growth for the market.

Information in this report includes:

• RNA Sequencing Market, 2022 and 2027
• RNA Sequencing Consumables Market, 2022 and 2027
• RNA Sequencing Equipment-Related Services Market, 2022 and 2027
• RNA Sequencing Software Market, 2022 and 2027
• RNA Sequencing Vendor Share
• Products on The Market
• Software Products
• Innovations
• Clinical Sequencing and Products on the Market

The competitive situation and deals are covered in respective chapters. The report was produced through a combination of primary research, secondary research, and internal databases, including SEC filings, product literature, corporate websites, conferences, journals, and trade publications.

Companies Profiled Include:

TABLE OF CONTENTS

CHAPTER 1: EXECUTIVE SUMMARY

• Table 1-1: RNA Sequencing Revenues by Product Segment (Consumables, Systems/Hardware, Service, and Software), 2022 (in millions of $)
• Figure 1-1: RNA Sequencing Revenues by Product Segment (Consumables, Systems/Hardware, Service, and Software), 2022 (percent)
• Scope and Methodology
• Report Structure

CHAPTER 2: MARKET TRENDS

• Introduction
• Trends
• Clinical Diagnostics, Clinical Research Applications
• Cancer - leukemia/ hematological diseases; solid tumors
• Infectious diseases
• Rare inherited/ genetic diseases
  • Table 2-1: Selected RNA-Seq Diagnostic/ Clinical Products and Technologies
• COVID-19
• Illumina's Diverse Range of Products
• Other Companies' NGS Products and Technologies
• CDC's SPHERES Consortium
• Ongoing Introductions of New Products
  • Table 2-2: RNA-Sequencing Product Introductions, October 2018- July 2023
• Single-cell RNA Sequencing
• Selected Products/ Technologies
  • Table 2-3: Selected RNA-Seq Products and Technologies
• Software/Bioinformatics
  • Table 2-4: Selected RNA-Seq Software and Related IT Tools
• Partnerships, Acquisitions, Deals in Many Areas
  • Table 2-5: RNA-Seq Collaborations, Acquisitions and Other Deals, October 2014-August 2023

CHAPTER 3: MARKET ANALYSIS

• Market Analysis
  • Table 3-1: RNA Sequencing Revenues, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2022-2027 (in millions of dollars)
  • Figure 3-1: RNA Sequencing Revenues, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2022-2027 (in millions of dollars)
  • Table 3-2: RNA Sequencing Revenue Shares, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2022-2027 (percent)
  • Figure 3-2: RNA Sequencing Revenue Shares, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2022 (percent)
  • Figure 3-3: RNA Sequencing Revenue Shares, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2027 (percent)
• Market Shares
  • Table 3-3: RNA Sequencing Market Revenue Share, by Leading Companies (Illumina, Thermo, and Other), 2022 (millions of dollars and percent)
  • Figure 3-4: RNA Sequencing Revenue Shares, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2022 (percent)
  • Table 3-4: RNA Sequencing Market Revenue Share, by Region (North America, Europe, APAC, and Rest of World), 2021 (millions of dollars and percent)
  • Figure 3-5: RNA Sequencing Market Revenue Share, by Region (North America, Europe, APAC, and Rest of World), 2021 (percent)

CHAPTER 4: COMPANY PROFILES

• Company Profiles
  • 10X Genomics
  • Agilent Technologies
  • Illumina
  • New England Biolabs
  • Oxford Nanopore Technologies
  • Pacific Biosciences (PacBio)
  • Standard BioTools
  • Takara Bio Inc.
  • Tecan
  • Thermo Fisher Scientific